Tudor Investment Corp
CORT icon

Tudor Investment Corp’s Corcept Therapeutics CORT Stock Holding History

Tudor Investment Corp’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Buy
25,916
+18,848
+267% +$705K ﹤0.01% 2340
2025
Q4 		$246K Buy
+7,068
New +$555K ﹤0.01% 3168
2025
Q1 		– Sell
-53,169
Closed -$3.24M – 3154
2024
Q4 		$2.68M Buy
+53,169
New +$2.79M 0.01% 1060
2023
Q4 		– Sell
-51,242
Closed -$1.4M – 2433
2023
Q3 		$1.4M Buy
51,242
+25
+0% +$724 0.01% 1118
2023
Q2 		$1.14M Buy
51,217
+3,338
+7% +$76.8K 0.01% 1244
2023
Q1 		$1.04M Buy
+47,879
New +$1.05M 0.02% 1174
2022
Q4 		– Sell
-34,457
Closed -$883K – 2460
2022
Q3 		$883K Buy
+34,457
New +$922K 0.02% 996
2020
Q3 		– Sell
-77,417
Closed -$1.3M – 1326
2020
Q2 		$1.3M Sell
77,417
-95,643
-55% -$1.34M 0.06% 392
2020
Q1 		$2.06M Buy
173,060
+13,606
+9% +$168K 0.18% 97
2019
Q4 		$1.93M Sell
159,454
-15,908
-9% -$221K 0.09% 294
2019
Q3 		$2.48M Sell
175,362
-61,904
-26% -$761K 0.09% 262
2019
Q2 		$2.65M Buy
237,266
+21,806
+10% +$243K 0.08% 241
2019
Q1 		$2.53M Buy
215,460
+53,058
+33% +$659K 0.1% 214
2018
Q4 		$2.17M Buy
162,402
+135,902
+513% +$1.8M 0.04% 176
2018
Q3 		$372K Buy
+26,500
New +$370K 0.01% 778
2018
Q2 		– Sell
-10,364
Closed -$170K – 1069
2018
Q1 		$170K Buy
+10,364
New +$192K 0.01% 888
2017
Q4 		– Sell
-34,734
Closed -$670K – 1101
2017
Q3 		$670K Buy
+34,734
New +$518K 0.02% 547
2016
Q4 		– Sell
-23,564
Closed -$153K – 1423
2016
Q3 		$153K Sell
23,564
-4,885
-17% -$28.4K ﹤0.01% 1298
2016
Q2 		$155K Sell
28,449
-350
-1% -$1.82K ﹤0.01% 1460
2016
Q1 		$135K Buy
28,799
+1,700
+6% +$6.62K ﹤0.01% 1578
2015
Q4 		$135K Buy
27,099
+5,820
+27% +$26.3K ﹤0.01% 1495
2015
Q3 		$80K Buy
+21,279
New +$108K ﹤0.01% 1453

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Tudor Investment Corp's CORT Position: Q1 2026 in Review

Tudor Investment Corp increased its Corcept Therapeutics (CORT) stake by 267% in Q1 2026, buying an estimated $705K and bringing the position to 25,916 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2340.

Tudor Investment Corp first reported a position in CORT in Q3 2015 and has held it in 22 quarters since. The position peaked at $2.68M in Q4 2024. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Tudor Investment Corp held 25,916 shares of Corcept Therapeutics worth $1.04M as of Q1 2026.
  • Tudor Investment Corp bought 18,848 Corcept Therapeutics shares in Q1 2026, an estimated $705K.
  • Corcept Therapeutics made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2340 holding.
  • Tudor Investment Corp first reported a position in Corcept Therapeutics in Q3 2015 and has held it in 22 quarters since.
  • Tudor Investment Corp's Corcept Therapeutics position peaked at $2.68M in Q4 2024.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.